98 related articles for article (PubMed ID: 26646120)
1. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
[TBL] [Abstract][Full Text] [Related]
2. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
[TBL] [Abstract][Full Text] [Related]
3. Survey among ESGE members on leiomyosarcoma morcellation incidence.
Tanos V; Brölmann H; DeWilde RL; O'Donovan P; Symeonidou E; Campo R
Gynecol Surg; 2017; 14(1):25. PubMed ID: 29238287
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.
Siedhoff MT; Wheeler SB; Rutstein SE; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL
Am J Obstet Gynecol; 2015 May; 212(5):591.e1-8. PubMed ID: 25817518
[TBL] [Abstract][Full Text] [Related]
5. Uterine Morcellation: Fact and Fiction Surrounding the Recent Controversy.
Winner B; Biest S
Mo Med; 2017; 114(3):176-180. PubMed ID: 30228576
[TBL] [Abstract][Full Text] [Related]
6. Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.
Wright JD; Cui RR; Wang A; Chen L; Tergas AI; Burke WM; Ananth CV; Hou JY; Neugut AI; Temkin SM; Wang YC; Hershman DL
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26449386
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis.
Liu H; Zhu Y; Zhang GN; Wang C; Li C; Shi Y
Sci Rep; 2016 Aug; 6():31229. PubMed ID: 27503773
[TBL] [Abstract][Full Text] [Related]
8. Impact of perioperative characteristics on the recurrence risk and survival of patients with uterine leiomyosarcoma.
Gracia M; Yildirim Y; Macuks R; Mancari R; Achimas-Cadariu P; Cusine-Lopez L; Novak Z; Dallaku K; Zapardiel I;
Int J Gynaecol Obstet; 2023 Dec; 163(3):868-874. PubMed ID: 37485666
[TBL] [Abstract][Full Text] [Related]
9. Rate of Leiomyosarcomas during Surgery for Uterine Fibroids: 8-Year Experience of a Single Center.
Zouzoulas D; Tsolakidis D; Pavlidi OI; Pappas PD; Theodoridis T; Pados G; Pervana S; Pazarli E; Grimbizis G
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137623
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Ultrasound in the Diagnosis of Uterine Leiomyomas and Sarcomas.
Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.
Casarin J; Ghezzi F; Lembo A; Artuso V; Schivardi G; Galati EF; Ambrosoli AL; Bogani G; Multinu F; Cromi A
J Surg Oncol; 2024 Mar; 129(3):517-522. PubMed ID: 37974522
[TBL] [Abstract][Full Text] [Related]
12. A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy.
Karass M; Mondal P; Alkayem M; Ojo A; Aronow WS; Puccio C
Ann Transl Med; 2016 Oct; 4(19):374. PubMed ID: 27826577
[TBL] [Abstract][Full Text] [Related]
13. U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?
Parker WH; Kaunitz AM; Pritts EA; Olive DL; Chalas E; Clarke-Pearson DL; Berek JS;
Obstet Gynecol; 2016 Jan; 127(1):18-22. PubMed ID: 26646134
[TBL] [Abstract][Full Text] [Related]
14. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
15. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
16. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
Ricci S; Stone RL; Fader AN
Gynecol Oncol; 2017 Apr; 145(1):208-216. PubMed ID: 28209496
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
18. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
[TBL] [Abstract][Full Text] [Related]
19. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]